The New Front Line of STI Diagnosis - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

The New Front Line of STI Diagnosis

  • By

  • Nikolina Babic

  • Sheldon Campbell

  • Kate Crawford

  • November 18, 2026

  • 7 min

Share

Objective:

The article describes point-of-care (POC) testing for sexually transmitted infections, including available assays, potential benefits, and the role of laboratory professionals in implementation.

Approach:
  • Testing model: POC tests are performed close to the patient, outside the traditional clinical laboratory, and typically provide results within minutes to an hour.
  • Available tests: Rapid antibody and antigen-antibody tests for syphilis and HIV have been used for years and can provide results in less than 30 minutes. Newer FDA-cleared, CLIA-waived molecular assays detect chlamydia and gonorrhea in approximately 20 minutes; some newer platforms also test for Mycoplasma genitalium and Trichomonas vaginalis.
  • Implementation: Pathologists and laboratory professionals contribute to test selection, implementation, quality assurance, and oversight.
Key Findings:
  • Results available during the same encounter can support diagnosis and treatment without depending on a later follow-up visit.
  • The article describes potential benefits including reduced loss to follow-up, less reliance on empiric treatment, and improved access for people facing barriers to conventional testing.
  • Accurate rapid testing may reduce reliance on syndromic treatment, support antimicrobial stewardship, and limit unnecessary antibiotic exposure.
  • POC tests for herpes simplex virus and human papillomavirus are not yet available.
Interpretation:

The article describes POC testing as a complement to centralized laboratory services, particularly where loss to follow-up is common or rapid treatment is important.

Limitations:
  • Molecular platforms may involve substantial cost and operational complexity.
  • Some assays have restrictions on specimen types, including limited approval for extragenital testing.
  • CLIA-waived tests still require staff training, competency assessment, and quality control.
  • Workflow, staffing, and testing volume may make implementation impractical in some settings.
Conclusion:

The article states that POC STI testing requires appropriate training, quality controls, and integration into health care systems.

Sources:

Original Source(s)

Related Content